Vertex Pharmaceuticals Inc. buy Wells Fargo & Company
Start price
10.12.25
/
50%
€380.75
Target price
10.12.26
€442.18
Performance (%)
4.73%
Price
09.01.26
€398.75
Summary
This prediction is currently active. The BUY prediction by Wells_Fargo___Compan shows slight gains of 4.73%. This prediction currently runs until 10.12.26. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Vertex Pharmaceuticals Inc. | 2.923% |
| iShares Core DAX® | 2.659% |
| iShares Nasdaq 100 | 0.916% |
| iShares Nikkei 225® | 2.426% |
| iShares S&P 500 | 1.230% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals (NASDAQ:VRTX) had its price target raised by analysts at Wells Fargo & Company from $460.00 to $515.00. They now have an "overweight" rating on the stock.
Ratings data for VRTX provided by MarketBeat
Stopped prediction by Wells_Fargo___Compan for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€325.60
06.08.25
06.08.25
€397.62
06.08.26
06.08.26
22.47%
09.01.26
09.01.26
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€398.50
10.01.25
10.01.25
€447.72
10.01.26
10.01.26
0.06%
09.01.26
09.01.26
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€439.95
24.06.24
24.06.24
€516.65
24.06.25
24.06.25
-11.44%
25.06.25
25.06.25
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€383.95
06.02.24
06.02.24
€502.09
06.02.25
06.02.25
21.15%
07.02.25
07.02.25